Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S., MSc In Diabetes & Endocrinology, DHHM, Diabetes Certificate Course
Diabetologist
M.B.B.S., MSc In Diabetes & Endocrinology, DHHM, Diabetes Certificate Course
Gastroenterologist
M.B.B.S, F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
General Physician
M.B.B.S., M.Phil, Masters of Health Administration, Masters Family Medicine
General Physician
M.B.B.S., M.Phil, Masters of Health Administration, Masters Family Medicine
Internal Medicine Specialist
M.B.B.S., M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCEM
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures